Lightpoint Medical Limited clinical trials
Acquired by Telix Pharmaceuticals Limited, Nov 1, 2023 · source ↗
The registry lists 7 studies whose lead sponsor is Lightpoint Medical Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2020.
Before and after it joined Telix Pharmaceuticals Limited
- First submitted before Lightpoint Medical Limited became part of Telix Pharmaceuticals Limited
- 7
- First submitted after Lightpoint Medical Limited became part of Telix Pharmaceuticals Limited
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Status
- Status unknown
- 4
- Completed
- 2
- Withdrawn
- 1
Registry sponsor names on this page
- Lightpoint Medical Limited7 studies
Something wrong with this grouping? Tell us on the Telix Pharmaceuticals Limited page.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. All Telix Pharmaceuticals Limited studies →
- Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate CancerStatus unknownNCT04632251Not applicable
Sponsor listed in the registry: Lightpoint Medical Limited · First submitted before Lightpoint Medical Limited became part of Telix Pharmaceuticals Limited
- The LightPath® and 68Ga-RM2 in Breast Cancer StudyStatus unknownNCT03731026Phase 3
Sponsor listed in the registry: Lightpoint Medical Limited · First submitted before Lightpoint Medical Limited became part of Telix Pharmaceuticals Limited
- The LightPath® Breast Cancer StudyStatus unknownNCT02666079Not applicable
Sponsor listed in the registry: Lightpoint Medical Limited · First submitted before Lightpoint Medical Limited became part of Telix Pharmaceuticals Limited
- Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour SurgeryWithdrawnNCT02446379
Sponsor listed in the registry: Lightpoint Medical Limited · First submitted before Lightpoint Medical Limited became part of Telix Pharmaceuticals Limited
- The Breast Surgery EnLight and LightPath Imaging System StudyStatus unknownNCT02151071Phase 1/2
Sponsor listed in the registry: Lightpoint Medical Limited · First submitted before Lightpoint Medical Limited became part of Telix Pharmaceuticals Limited
- LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical SpecimensCompletedNCT02037269
Sponsor listed in the registry: Lightpoint Medical Limited · First submitted before Lightpoint Medical Limited became part of Telix Pharmaceuticals Limited
- PRIME - PRostate Imaging for Margin EvaluationCompletedNCT02151097
Sponsor listed in the registry: Lightpoint Medical Limited · First submitted before Lightpoint Medical Limited became part of Telix Pharmaceuticals Limited